TP53 and neoplasm: Selecting the patients that will profit the most from each therapy, for example evaluating patients’ specific immune profile or the tumor dependency on p53 and protein trafficking, will be pivotal in paving the road toward a truly personalized medicine, where each patient or group of patients will receive a drug combination more suitable for their characteristics.